These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23896273)

  • 1. Effect of pigmentation on photodynamic therapy - Authors' reply.
    Arits A; Kelleners-Smeets NW
    Lancet Oncol; 2013 Aug; 14(9):e340. PubMed ID: 23896273
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of pigmentation on photodynamic therapy.
    Apalla Z; Lallas A; Sotiriou E; Ioannides D
    Lancet Oncol; 2013 Aug; 14(9):e339-40. PubMed ID: 23896270
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary on 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial'.
    Nijsten T
    Br J Dermatol; 2015 Jan; 172(1):12. PubMed ID: 25581586
    [No Abstract]   [Full Text] [Related]  

  • 4. Treating basal-cell carcinoma in a real life setting.
    Dummer R
    Lancet Oncol; 2013 Jun; 14(7):572-3. PubMed ID: 23683749
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal'.
    Arits A; Nelemans P; Kelleners-Smeets N
    Br J Dermatol; 2015 Jan; 172(1):11-2. PubMed ID: 25581585
    [No Abstract]   [Full Text] [Related]  

  • 6. Complete remission of nodular basal cell carcinoma after combined treatment with photodynamic therapy and imiquimod 5% cream.
    Devirgiliis V; Panasiti V; Curzio M; Gobbi S; Rossi M; Roberti V; Calvieri S
    Dermatol Online J; 2008 Feb; 14(2):25. PubMed ID: 18700128
    [No Abstract]   [Full Text] [Related]  

  • 7. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
    Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal.
    Lecluse LL; Spuls PI
    Br J Dermatol; 2015 Jan; 172(1):8-10. PubMed ID: 25581584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Aminolevulinic acid based photodynamic therapy for basal cell carcinoma: a 10-years follow-up study.
    Christensen E
    Stomatologija; 2013; 15(3):ii. PubMed ID: 24511763
    [No Abstract]   [Full Text] [Related]  

  • 10. Fractionated 5-aminolevulinic acid photodynamic therapy in the treatment of a giant recurrent superficial basal cell carcinoma.
    Sotiriou E; Apalla Z; Ioannides D
    Photodermatol Photoimmunol Photomed; 2009 Dec; 25(6):331-2. PubMed ID: 19906170
    [No Abstract]   [Full Text] [Related]  

  • 11. The choice and measurement of fluence in photodynamic therapy for superficial basal cell carcinoma: reply from the authors.
    Roozeboom MH; Arits AH; Kelleners-Smeets NW
    Br J Dermatol; 2015 Oct; 173(4):1106-7. PubMed ID: 26154079
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU).
    Roozeboom MH; van Kleef L; Arits AH; Mosterd K; Winnepenninckx VJ; van Marion AM; Nelemans PJ; Kelleners-Smeets NW
    J Am Acad Dermatol; 2015 Jul; 73(1):93-8. PubMed ID: 25935596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroepithelioma of Pinkus: poor response to topical photodynamic therapy.
    Park MY; Kim YC
    Eur J Dermatol; 2010; 20(1):133-4. PubMed ID: 19919909
    [No Abstract]   [Full Text] [Related]  

  • 14. Problems associated with the use of broad-band illumination sources for photodynamic therapy.
    Stringer MR
    Phys Med Biol; 1995 Oct; 40(10):1733-5. PubMed ID: 8532752
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma.
    Arits AH; Spoorenberg E; Mosterd K; Nelemans P; Kelleners-Smeets NW; Essers BA
    Br J Dermatol; 2014 Dec; 171(6):1501-7. PubMed ID: 24749843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison in real clinical practice of methyl aminolevulinate photodynamic therapy and surgery for small superficial basal cell carcinoma: 3-year recurrence rates and cosmetic outcomes.
    Sebaratnam DF; Venugopal SS; Murrell DF
    J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):117-8. PubMed ID: 20456551
    [No Abstract]   [Full Text] [Related]  

  • 17. The choice and measurement of fluence in photodynamic therapy for superficial basal cell carcinoma.
    van der Beek N; Bjerring P; Neumann HA
    Br J Dermatol; 2015 Oct; 173(4):1105-6. PubMed ID: 26146762
    [No Abstract]   [Full Text] [Related]  

  • 18. Noninvasive assessment for noninvasive treatments in dermato-oncology.
    Segura S
    Br J Dermatol; 2013 Jan; 168(1):3-4. PubMed ID: 23278556
    [No Abstract]   [Full Text] [Related]  

  • 19. Epidermoid cysts mimicking recurrence of superficial basal cell carcinoma following photodynamic therapy.
    Ghaffar SA; Clements SE; Lear JT
    Clin Exp Dermatol; 2007 Mar; 32(2):223-4. PubMed ID: 17137478
    [No Abstract]   [Full Text] [Related]  

  • 20. Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response.
    Morton CA; MacKie RM; Whitehurst C; Moore JV; McColl JH
    Arch Dermatol; 1998 Feb; 134(2):248-9. PubMed ID: 9487227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.